Ayahuasca and Its DMT- and β-carbolines - Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment
This mouse study finds that a moderate (not high or low) dose of ayahuasca can help with alcohol use disorder (AUD). This was done using the conditioned place preference (CPP) paradigm in male mice.
Authors
- Paulo Barbosa
- Ruben Laukkonen
- Laís Fernanda Berro
Published
Abstract
Ayahuasca is a hallucinogenic beverage produced from the decoction of Banisteriopsis caapi (Bc) and Psychotria viridis (Pv), β-carboline- and N,N-dimethyltryptamine(DMT)-containing plants, respectively. Accumulating evidence suggests that ayahuasca may have therapeutic effects on ethanol abuse. It is not known, however, whether its effects are dependent on the presence of DMT or if non-DMT-containing components would have therapeutic effects. The aim of the present study was to investigate the rewarding properties of ayahuasca (30, 100, and 300 mg/kg, orally), Bc (132, 440, and 1320 mg/kg, orally) and Pv (3.75, 12.5 and 37.5 mg/kg, i.p.) extracts and their effects on ethanol (1.8 g/kg, i.p.) reward using the conditioned place preference (CPP) paradigm in male mice. Animals were conditioned with ayahuasca, Bc or Pv extracts during 8 sessions. An intermediate, but not a high, dose of ayahuasca induced CPP in mice. Bc and Pv did not induce CPP. Subsequently, the effects of those extracts were tested on the development of ethanol-induced CPP. Ayahuasca, Bc or Pv were administered before ethanol injections during conditioning sessions. While Bc and Pv exerted no effects on ethanol-induced CPP, pretreatment with ayahuasca blocked the development of CPP to ethanol. Finally, the effects of a post-ethanol-conditioning treatment with ayahuasca, Bc or Pv on the expression of ethanol-induced CPP were tested. Animals were conditioned with ethanol, and subsequently treated with either ayahuasca, Bc or Pv in the CPP environment previously associated with saline or ethanol for 6 days. Animals were then reexposed to ethanol and ethanol-induced CPP was quantified on the following day. Treatment with all compounds in the ethanol-paired environment blocked the expression of ethanol-induced CPP. Administration of an intermediate, but not a high, dose of ayahuasca and Bc, as well as Pv administration, in the saline-paired compartment blocked the expression of ethanol-induced CPP. The present study sheds light into the components underlying the therapeutic effects of ayahuasca on ethanol abuse, indicating that ayahuasca and its plant components can decrease ethanol reward at doses that do not exert abuse liability. Importantly, the treatment environment seems to influence the therapeutic effects of ayahuasca and Bc, providing important insights into clinical practice.
Research Summary of 'Ayahuasca and Its DMT- and β-carbolines - Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment'
Introduction
Alcohol (ethanol, Eth) use disorder remains a major global health problem and current treatments are only partially effective, motivating investigation of new approaches. Earlier clinical and observational work has suggested that ayahuasca (Aya), a brew made from Banisteriopsis caapi (Bc) and Psychotria viridis (Pv) that contains β-carbolines and N,N-dimethyltryptamine (DMT), may reduce substance use and craving, but it is unclear whether those effects reflect pharmacology of the plants themselves or contextual/religious factors associated with ayahuasca use. Ryabinin and colleagues set out to determine whether Aya and its constituent plant extracts have rewarding or anti-rewarding effects in mice, and whether those effects depend on DMT-containing versus non-DMT components. Using the conditioned place preference (CPP) paradigm, they tested (1) whether Aya, an extract of B. caapi (EBc) or an extract of P. viridis (EPv) produce CPP on their own, (2) whether pretreatment with those preparations alters the development of ethanol (Eth)-induced CPP, and (3) whether post-conditioning treatment in either the Eth-paired or saline-paired environment influences the expression of established Eth-induced CPP. The study therefore addresses both pharmacological contributions of DMT versus β-carbolines and the role of treatment context.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Cata-Preta, E. G., Serra, Y. A., Moreira-Junior, E. D. C., Reis, H. S., Kisaki, N. D., Libarino-Santos, M., Silva, R. R. R., Barros-Santos, T., Santos, L. C., Barbosa, P. C. R., Costa, J. L., Oliveira-Lima, A. J., Berro, L. F., & Marinho, E. A. V. (2018). Ayahuasca and Its DMT- and β-carbolines - Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment. Frontiers in Pharmacology, 9. https://doi.org/10.3389/fphar.2018.00561
References (11)
Papers cited by this study that are also in Blossom
Barbosa, P., Strassman, R. J., da Silveira, D. X. et al. · Comprehensive Psychiatry (2016)
da Silveira, D. X., Doering-Silveira, E., Grob, C. S. et al. · Journal of Psychoactive Drugs (2005)
Doering-Silveira, E., Grob, C. S., Dobkin de Rios, M. et al. · Journal of Psychoactive Drugs (2005)
Domínguez-Clavé, E., Soler, J., Elices, M. et al. · Brain Research Bulletin (2016)
Fábregas, J. M., González, D., Fondevila, S. et al. · Drug and Alcohol Dependence (2010)
Halpern, J. H., Sherwood, A. R., Passie, T. et al. · Medical Science Monitor (2008)
Loizaga-Velder, A., Verres, R. · Journal of Psychoactive Drugs (2014)
McKenna, D. · ACS Chemical Neuroscience (2004)
Nunes, A. A., Dos Santos, R. G., Osório, F. L. et al. · Journal of Psychoactive Drugs (2016)
Pires, A. P. S., De Oliveira, C. D. R., Moura, S. et al. · Phytochemical Analysis (2009)
Show all 11 referencesShow fewer
Thomas, G., Lucas, P., Rielle Capler, N. et al. · Current Drug Abuse Reviews (2013)
Cited By (6)
Papers in Blossom that reference this study
Calleja-Conde, J., Morales-García, J. A., Echeverry-Alzate, V. et al. · Addiction Biology (2022)
Maia, L. O., Massarentti, C. M., Tófoli, L.F. · Psychopharmacology (2022)
Henriques, G. M., Anjos-Santos, A., Rodrigues, I. R. et al. · Frontiers in Pharmacology (2021)
Rodrigues, L. S., Rossi, G. N., Rocha, J. M. et al. · European Archives of Psychiatry and Clinical Neuroscience (2021)
Dos Santos, R. G., Hallak, J. E. · Neuroscience and Biobehavioral Reviews (2020)
Garcia-Romeu, A., Davis, A. K., Fire Erowid et al. · Journal of Psychopharmacology (2019)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.